Refobacin Revision-3 Bone Cement Post-Market Study
brief summary
The goal of this post-market study is to confirm the safety, performance and clinical benefits of the Refobacin Revision-3 Bone Cement when used in knee or hip revision surgeries. This will be done by collecting information on: * removal of any metal components of the hip or knee implants used in combination with the cement * frequency and incidence of adverse events * overall pain and functional performance, subject quality of life, and radiographic parameters
detailed description
Multicenter, retrospective and prospective, non-controlled Post-Market Clinical Follow-Up (PMCF) study involving orthopedic surgeons skilled in knee or hip arthroplasty procedures.
Patients will be enrolled prospectively or retrospectively (minimum 3 years after their surgery, depending on the availability of the data.
official title
Post Market Clinical Follow-up Study on the Refobacin Revision-3 Bone Cement and Its Instrumentation